Benjamin Halladay
Chief Financial Officer
CFO
Analyst — Intern, Finance Department
Earnings-call appearances
-
Esperion Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-06
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-05
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q4 FY2024 Earnings Call2025-01-16
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-07
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q4 FY2023 Earnings Call2024-02-27
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-01
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-09
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q4 FY2022 Earnings Call2023-01-09
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-01
Esperion Therapeutics, Inc. (ESPR)